Showing results 1 – 8 of 8

Anees Chagpar

Associate Professor; Director, Assistant Director

Yale Cancer Center

Breast Cancer, Yale Cancer Center, breast surgeon, hereditary breast and ovarian cancer syndrome breast cancer, Breast Neoplasms, Global affairs, Healthcare

Anees is the Director of The Breast Center, Smilow Cancer Hospital at Yale-New Haven, an Associate Professor in the Department of Surgery, Yale School of Medicine, and the Assistant Director for Global Oncology at Yale Comprehensive Cancer Center. Born and

Healthcare, hospital administration, Medicine, Health system leadership

Practicing internal medicine physician who has served as chairman and CEO of the Virginia Mason Health System in Seattle since 2000. He is also chair of the National Patient Safety Foundation Lucian Leape Institute and immediate past chair of the Institute for Healthcare Improvement Board of Directors. During his tenure as chief executive, Virginia Mason has become a national leader in quality, safety and innovation resulting from its Toyota Production System-inspired lean management methodology, the Virginia Mason Production System. To schedule an interview with Dr. Kaplan, contact Virginia Mason Media Relations.

Healthcare, Health Policy, Public Health

drug shortages, Opioids, Medication Safety, Patient Safety, Pediatrics, Critical Care, hospital administration, Healthcare, Pharmacy, Polypharmacy

Deborah A. Pasko, Pharm.D., M.H.A., is the Sr. Director of Medication Safety and Quality at ASHP (American Society of Health-System Pharmacists). With more than 22 years of pharmacy practice experience, Dr. Pasko leads ASHP’s efforts to improve medication safety and reduce opioid misuse. 

Dr. Pasko’s role at ASHP includes working with the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Department of Health and Human Services (HHS), and the White House on national medication safety initiatives. She also serves as an advisor to the Institute for Safe Medication Practices (ISMP), the Joint Commission (TJC), the United States Pharmacopeia (USP) National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) safety committee, and the National Quality Forum (NQF).

Dr. Pasko earned her Bachelor of Pharmacy degree from the Ohio Northern University College of Pharmacy and her Doctor of Pharmacy degree from Idaho State University College of Pharmacy. She has a Masters of Health Administration from the Walden University School of Health Sciences and completed a fellowship in Nephrology and Critical Care at the University of Michigan College of Pharmacy. Dr. Pasko has received numerous awards including the Cheers Award for Medication Safety.

Bioethics, Safe Injection Sites, End Of Life Ethics, Health Care Reform, Catholic Bioethics, Healthcare Management and Religion, Beginning Of Life Issues, Assisted Reproductive Technologies, public health issues, Organ Transplantation, Medical Futility

Ge Bai

Associate Professor of Accounting, Health Policy, and Management

Johns Hopkins University Carey Business School

healthcare administration, finace, Accounting, healthcare pricing, Healthcare Management, Health Policy, Healthcare Access, healthcare business, healthcare decision making, Healthcare economics, healthcare information, Healthcare Law

Ge Bai, PhD, CPA is an associate professor of Accounting at Johns Hopkins Carey Business School and associate professor of Health Policy & Management at Johns Hopkins Bloomberg School of Public Health. She is an expert on health care pricing, policy, and management. Dr. Bai has written for the Wall Street Journal and published her studies in leading academic journals such as the New England Journal of Medicine, JAMA, JAMA Internal Medicine, Annals of Internal Medicine, and Health Affairs. Her work has been widely featured in ABC, Atlantic, CBS, CNN, Forbes, Fox News, Los Angeles Times, NBC, New York Times, NPR, The Guardian, U.S. News & World Report, Wall Street Journal, Washington Post, and other media and used in government regulations and congressional testimony. 

Veena Shankaran

Co-director of the Hutchinson Institute for Cancer Outcomes Research (HICOR) at Fred Hutch

Fred Hutchinson Cancer Research Center

Healthcare economics, healthcare economist, cost of healthcare, Cost of Care, cost of cancer care, Cancer Cost, value-based cancer care, Financial toxicity, financial toxicity of cancer, Drug Costs, Healthcare Costs

Dr. Veena Shankaran is a medical oncologist and healthcare economist whose research focuses on the cost of cancer care and how it impacts patients and their families. A nationally recognized physician-scientist, her current research is investigating the out-of-pocket costs that patients with gastrointestinal cancers experience as well as the cost-effectiveness of cancer therapy—studying how great care can be delivered without wasting resources. 

Along with Dr. Scott Ramsey, Dr. Shankaran co-directs the Hutchinson Institute for Cancer Outcomes Research (HICOR) at the Fred Hutchinson Cancer Research Center in Seattle, researching and assessing the cost effectiveness of healthcare and health-related quality of life. In addition to her role as co-director of HICOR, she is an associate member of the Public Health Sciences and Clinical Research divisions at Fred Hutch. She also serves as associate professor of Medical Oncology at the University of Washington School of Medicine.

Harold L. Paz

Exec. Vice Pres. & Chancellor for Health Affairs, The Ohio State University and CEO, Wexner Med Ctr.

Ohio State University Wexner Medical Center

Social determinants of health, Academic Health Centers, Future of Medicine, Health Sciences, Healthcare Access, Healthcare Industry

At Ohio State, Dr. Paz leads all seven health science colleges and serves as CEO of the $4-billion Wexner Medical Center enterprise, which includes seven hospitals, a nationally ranked college of medicine, over 20 research institutes, multiple ambulatory sites, an accountable care organization, and a health plan.
Before joining OSU in June 2019, Dr. Paz was executive vice president and chief medical officer at Aetna where he led clinical strategy and policy at the intersection of all of Aetna’s domestic and global businesses.  He reported to Aetna’s chairman and CEO and was a member of its executive committee.  Prior to joining Aetna in 2014, Dr. Paz served as president and CEO of the Penn State Hershey Health System, senior vice president for health affairs at the Pennsylvania State University, and dean of its College of Medicine for eight years.  Before his appointment at Penn State, he spent eleven years as dean of the Robert Wood Johnson Medical School and CEO of the Robert Wood Johnson University Medical Group.
Dr. Paz received his bachelor's degree from the University of Rochester, a master of science in life science engineering from Tufts University, and his medical degree from the University of Rochester School of Medicine and Dentistry.  He completed his residency at Northwestern University, where he served as chief medical resident.  Dr. Paz was a Eudowood Fellow in pulmonary and critical care medicine at Johns Hopkins Medical School.  In addition, he was a post-doctoral fellow in environmental health science at Johns Hopkins School of Hygiene and Public Health.

Showing results 1 – 8 of 8

Chat now!